Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,720 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I. Svensson B, et al. Among authors: keller c. Arthritis Rheum. 2005 Nov;52(11):3360-70. doi: 10.1002/art.21298. Arthritis Rheum. 2005. PMID: 16255010 Free article. Clinical Trial.
Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain.
He Y, Grether U, Taddio MF, Meier C, Keller C, Edelmann MR, Honer M, Huber S, Wittwer MB, Heer D, Richter H, Collin L, Hug MN, Hilbert M, Postmus AGJ, Stevens AF, van der Stelt M, Krämer SD, Schibli R, Mu L, Gobbi LC. He Y, et al. Among authors: keller c. Eur J Med Chem. 2022 Sep 9;243:114750. doi: 10.1016/j.ejmech.2022.114750. Online ahead of print. Eur J Med Chem. 2022. PMID: 36137365 Free article.
1,720 results